Variable | All patients (n = 187) |
---|---|
General condition | |
 Age (years), median (IQR) | 71 (62.8, 75) |
 The male, n (%) | 119 (63.63%) |
 BMI, mean (SD) | 23.91 (0.60) |
 Temperature (℃), median (IQR) | 36.8 (36.5, 37.7) |
 Heart rate, mean (SD) | 107 (4) |
 Breathing, median (IQR) | 20 (15, 21) |
 Mean arterial pressure (mmHg), mean (SD) | 81 (2) |
 Baseline Scr (μmol/L), median (IQR) | 68.85 (52.5, 80.9) |
Reason for ICU admission, n (%) | |
 Respiratory failure | 86 (45.99%) |
 Circulatory failure | 55 (29.41%) |
 Neurological diseases | 26 (13.9%) |
 Trauma | 8 (4.28%) |
 Others | 12 (6.42%) |
Previous medical history, n (%) | |
 Hypertension | 88 (47.05%) |
 Diabetes | 37 (19.78%) |
 Ischemic heart disease | 29 (15.51%) |
 Cerebrovascular disease | 53 (28.34%) |
 Chronic liver disease | 4 (2.14%) |
 Malignancy | 77 (41.18%) |
Laboratory examination | |
 WBC (109/L), median (IQR) | 15.58 (10, 23.18) |
 PLT (109/L), median (IQR) | 191.5 (107.75, 278.5) |
 PCT (ng/ml), median (IQR) | 6.85 (1.5, 17.03) |
 Scr (μmol/L), median (IQR) | 201.4 (100.53, 267.4) |
 BUN (mmol/L), median (IQR) | 14.55 (8.95, 26.98) |
 Total bilirubin (μmol/L), median (IQR) | 16.1 (10.02, 39.97) |
 Lactate (mmol/L), median (IQR) | 1.85 (1.43, 4.88) |
 Plasma NGAL (ng/ml), median (IQR) | 190.66 (138.93, 318.77) |
 pH, mean (SD) | 7.34 (0.11) |
 Potassium concentration (mmol/L), median (IQR) | 4.38 (4.02, 5.03) |
 Bicarbonate (mmol/L), median (IQR) | 19.8 (15.63, 22.48) |
Stage of AKI | |
 Stage 1, n (%) | 49 (26.20%) |
 Stage 2, n (%) | 36 (19.25%) |
 Stage 3, n (%) | 102 (54.55%) |
Others | |
 RRI, mean (SD) | 0.66 (0.08) |
 CVP (mmHg), median (IQR) | 9.5 (8, 11) |
 Mechanical ventilation, n (%) | 126 (67.38%) |
 CRRT, n (%) | 142 (75.94%) |
 Sepsis, n (%) | 107 (57.22%) |
 Time of FST to initiate CRRT (hours), mean (SD) | 8.35 (5.75) |
 SOFA score, mean (SD) | 8.58 (0.55) |
 APACHE II score, median (IQR) | 17.5 (15, 25) |